Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jul;174(7):W65.
doi: 10.7326/L21-0375. Epub 2021 Jun 15.

Update Alert: Remdesivir for Adults With COVID-19

Anjum S Kaka  1 , Roderick MacDonald  2 , Eric J Linskens, Timothy J Wilt  1
Affiliations
Comment

Update Alert: Remdesivir for Adults With COVID-19

Anjum S Kaka et al. Ann Intern Med. 2021 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L21-0375.

Comment on

References

    1. Wilt TJ , Kaka AS , MacDonald R , et al. Remdesivir for adults with COVID-19: a living systematic review for American College of Physicians practice points. Ann Intern Med. 2021;174:209-220. [PMID: ]. doi: 10.7326/M20-5752 - DOI - PMC - PubMed
    1. Kaka AS , MacDonald R , Greer N , et al. Major update: remdesivir for adults with COVID-19: a living systematic review and meta-analysis for the American College of Physicians practice points. Ann Intern Med. 2021;174:663-672. [PMID: ]. doi: 10.7326/M20-8148 - DOI - PMC - PubMed
    1. Kaka A, MacDonald R, Greer N, et al. Surveillance update–02/08/21. Ann Intern Med. 10 February 2021. Accessed at https://www.acpjournals.org/doi/10.7326/M20-8148 on 8 June 2021.
    1. Mahajan L , Singh AP , . Clinical outcomes of using remdesivir in patients with moderate to severe COVID-19: a prospective randomised study. Indian J Anaesth. 2021;65:S41-S46. [PMID: ] doi: 10.4103/ija.IJA_149_21 - DOI - PMC - PubMed
    1. Spinner CD , Gottlieb RL , Criner GJ , et al; GS-US-540-5774 Investigators. Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial. JAMA. 2020;324:1048-1057. [PMID: ] doi: 10.1001/jama.2020.16349 - DOI - PMC - PubMed